CBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology
By: Colorado BioScience Association Date: 04/04/2019
Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science
Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization (BIO) honored Senator Michael Bennet and Representative Diana DeGette today as Innovators in Biotechnology. Senator Bennet and Congresswoman DeGette received the award in conjunction with today’s BIO Legislative Day Fly-In.
BIO’s Innovator in Biotechnology award recognizes Members of Congress who have been collaborative partners, advocates, and champions of the biotechnology and life science industries.
“The life science industry in Colorado provides high-paying jobs for close to 30,000 Colorado residents. Senator Bennet and Congresswoman DeGette have been invaluable advocates for the bioscience ecosystem,” said Jennifer Jones Paton, President and Chief Executive Officer of the Colorado BioScience Association. “On behalf of the Colorado life science industry and the patients we serve, we thank them for their outstanding leadership and dedication to supporting the innovative capacity and job-creating potential of American life science companies.”
“Senator Bennet and Congresswoman DeGette have been stalwart advocates for sound public policies that advance the jobs creating potential of America’s biotechnology industry as we address the most pressing medical, agricultural, industrial and environmental challenges facing our nation and the world,” said BIO President and CEO Jim Greenwood. “Their commitment to support the needs of America’s innovative life science companies allows them to focus on what matters – delivering life-saving and life-enhancing products.”
More than 200 biotechnology industry representatives from over 40 states, representing hundreds of thousands of American workers, will participate in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants will discuss issues critical to the biotechnology industry, including drug development, discovery and delivery reforms, targeting abuses of the U.S. patent system while protecting innovation, providing adequate reimbursement for vital therapies under Medicare, FDA funding, trade, tax policy, Farm Bill Implementation, protecting the Renewable Fuel Standard and capital formation issues relevant to biotechnology companies.
About the Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention,the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.